Supporting the designation of July 19, 2023, as "Glioblastoma Awareness Day".

Bill 118 HRES 425, also known as the "Glioblastoma Awareness Day" bill, aims to designate July 19, 2023, as a day to raise awareness about glioblastoma, a rare and aggressive form of brain cancer. The bill highlights the importance of educating the public about this devastating disease and the need for increased research funding to find a cure.

Glioblastoma is known for its high mortality rate and limited treatment options, making it a significant public health concern. By designating July 19th as "Glioblastoma Awareness Day," the bill seeks to bring attention to the challenges faced by patients and their families, as well as the urgent need for advancements in treatment and care.

The bill emphasizes the importance of early detection and diagnosis, as well as the critical role of healthcare providers in supporting patients with glioblastoma. It also recognizes the resilience and strength of individuals living with this disease, as well as the dedication of researchers and healthcare professionals working to improve outcomes for patients. Overall, Bill 118 HRES 425 serves as a call to action for increased awareness, research, and support for individuals affected by glioblastoma. By shining a spotlight on this devastating disease, the bill aims to inspire hope and progress in the fight against glioblastoma.